AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

BACKGROUND: Aldo-keto reductase family 1 member C3 (AKR1C3) is a key steroidogenic enzyme that is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). The aim of this study was to investigate the correlation between the express...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tian, Yuantong, Zhao, Lijing, Zhang, Haitao, Liu, Xichun, Zhao, Lijuan, Zhao, Xuejian, Li, Yi, Li, Jing
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3939640/
https://ncbi.nlm.nih.gov/pubmed/24571686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-9-42
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars